KI-Beratung Beta

Produktbild: Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics
Band 20

Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics

Fr. 119.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical...

Beschreibung

In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.
  • Contains 17 relevant, practice-oriented topics including the changing epidemiology of cardiac amyloidosis; arrhythmic stratification of cardiac amyloidosis: state of the art; specific therapy in ATTR-related cardiomyopathy: future perspectives beyond tafamidis; and more.
  • Provides in-depth clinical reviews on amyloid cardiomyopathies, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

13.06.2024

Herausgeber Giuseppe Limongelli + weitere
Verlag Elsevier Health Science

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

13.06.2024

Herausgeber
Verlag Elsevier Health Science
Seitenzahl

240

Maße (L/B/H)

25.4/17.8/0.9 cm

Gewicht

430 g

Sprache

Englisch

ISBN

978-0-443-12143-2

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Health Science
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics
  • Amyloidosis and Amyloidogenesis: One Name, Many Diseases
    Pathophysiology of Cardiac Amyloidosis
    The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis
    Clinical Use of Biomarkers in Cardiac Amyloidosis
    Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications
    The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
    Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update
    Standard Therapy in Cardiac Amyloidosis: What is Known, What is Gray
    Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones
    Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis